Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David jones

Showing results (391-400 of 533) with videos related to

Pageof 54
Sort By:
FEMS Microbiology Letters|November 13, 2020
High-density transposon libraries utilising outward-oriented promoters identify mechanisms of action and resistance to antimicrobialsChris Coward, Gopujara Dharmalingham, Omar Abdulle, et al.
Hepatology Communications|March 13, 2019
A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary CholangitisMarlyn J Mayo, Paul J Pockros, David Jones, et al.
Mabs|February 9, 2016
Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challengesKathryn Chapman, Akosua Adjei, Paul Baldrick, et al.
Biotechnology Progress|February 8, 2003
High-level expression of recombinant IgG in the human cell line per.c6David Jones, Nathalie Kroos, Regina Anema, et al.
Journal of Pharmacological and Toxicological Methods|September 1, 2020
Is there a role for the no observed adverse effect level in safety pharmacology?Tomas Mow, Ninette K Andersen, Nils Dragsted, et al.
Klinische Padiatrie|July 12, 2018
Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making - A Selected Case SeriesHeidi Bächli, Jonas Ecker, Cornelis van Tilburg, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 28, 2024
Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in CanadaJoanne Britto, Anne Holbrook, Haowei Sun, et al.
JHEP Reports : Innovation in Hepatology|October 21, 2022
Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitisChristoph Schramm, Heiner Wedemeyer, Andrew Mason, et al.
Heart Rhythm|August 26, 2023
Atrioventricular nodal ablation is an effective management strategy for atrial fibrillation in patients with hypertrophic cardiomyopathyCharles Butcher, Saffron Rajappan, Amy L Wharmby, et al.
Journal of Environmental Management|June 30, 2022
Supporting habitat restoration in the northern Gulf of Mexico through synthesis of data on multiple and interacting benefits and stressorsErin Kiskaddon, Harris Bienn, Scott A Hemmerling, et al.
Pageof 54

Showing results (391-400 of 533) with videos related to

Sort By:
Pageof 54
FEMS Microbiology Letters|November 13, 2020
High-density transposon libraries utilising outward-oriented promoters identify mechanisms of action and resistance to antimicrobialsChris Coward, Gopujara Dharmalingham, Omar Abdulle, et al.
Hepatology Communications|March 13, 2019
A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary CholangitisMarlyn J Mayo, Paul J Pockros, David Jones, et al.
Mabs|February 9, 2016
Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challengesKathryn Chapman, Akosua Adjei, Paul Baldrick, et al.
Biotechnology Progress|February 8, 2003
High-level expression of recombinant IgG in the human cell line per.c6David Jones, Nathalie Kroos, Regina Anema, et al.
Journal of Pharmacological and Toxicological Methods|September 1, 2020
Is there a role for the no observed adverse effect level in safety pharmacology?Tomas Mow, Ninette K Andersen, Nils Dragsted, et al.
Klinische Padiatrie|July 12, 2018
Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making - A Selected Case SeriesHeidi Bächli, Jonas Ecker, Cornelis van Tilburg, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 28, 2024
Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in CanadaJoanne Britto, Anne Holbrook, Haowei Sun, et al.
JHEP Reports : Innovation in Hepatology|October 21, 2022
Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitisChristoph Schramm, Heiner Wedemeyer, Andrew Mason, et al.
Heart Rhythm|August 26, 2023
Atrioventricular nodal ablation is an effective management strategy for atrial fibrillation in patients with hypertrophic cardiomyopathyCharles Butcher, Saffron Rajappan, Amy L Wharmby, et al.
Journal of Environmental Management|June 30, 2022
Supporting habitat restoration in the northern Gulf of Mexico through synthesis of data on multiple and interacting benefits and stressorsErin Kiskaddon, Harris Bienn, Scott A Hemmerling, et al.
Pageof 54